W. Halangk et al., TRYPSINOGEN ACTIVATION IN RAT PANCREATIC ACINAR-CELLS HYPERSTIMULATEDBY CERULEIN, Biochimica et biophysica acta. Molecular basis of disease, 1362(2-3), 1997, pp. 243-251
Inappropriate trypsinogen activation is discussed as an early intracel
lular event in the secretagogue-induced model of acute pancreatitis. H
owever, the mechanisms by which trypsinogen is activated are not well
characterized. In the present work, trypsinogen activation was studied
in intact acinar cells using bis-(CBZ-arginyl)-Rhodamine 110 [(CBZ-Ar
g)(2)-Rho 110] as a cell-permeant substrate for trypsin and also indep
endently via the formation of trypsinogen activation peptide (TAP). Pr
eincubation with 10nM caerulein increased the Rho 110-substrate cleava
ge more than threefold. This proteolytic activity was fully sensitive
to a benzamidine (BA)-type serine protease inhibitor. The appearance o
f enzymatic activity was paralleled by the formation of TAP. The lack
of effect of the high-molecular soybean trypsin inhibitor indicates an
intracellular substrate cleavage. The cathepsin B inhibitor CA-074 pr
evented neither the caerulein-induced formation of TAP nor the (CBZ-Ar
g)(2) Rho 110-cleaving activity. BA inhibited the Rho 110-substrate cl
eavage and significantly reduced the TAP formation. These results show
that trypsinogen activation in caerulein-hyperstimulated acinar cells
may occur independently of the activity of cathepsin B. On the contra
ry, the effect of BA suggests the role of a serine protease in trypsin
ogen activation. (C) 1997 Elsevier Science B.V.